Hizentra (human immunoglobulin g) NDC 44206-455

NDC codes

FDA NDC Directory

Product NDC (as listed)44206-455Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44206-0455Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44206-455-10	44206045510	1 VIAL, SINGLE-DOSE in 1 CARTON (44206-455-10) / 50 mL in 1 VIAL, SINGLE-DOSE (44206-455-93)Marketed from Oct 3, 2011
44206-455-25	44206045525	1 SYRINGE in 1 CARTON (44206-455-25) / 50 mL in 1 SYRINGE (44206-455-97)Marketed from Oct 3, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hizentra
Generic name (nonproprietary): human immunoglobulin g
Active ingredients: Human immunoglobulin g — .2 g/mL
Dosage form: Liquid
Route: Subcutaneous
Labeler: CSL Behring AG
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125350
Marketing start: Oct 3, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Antigen Neutralization (Mechanism)Immunoglobulins (Chemical structure)Passively Acquired Immunity (Physiologic effect)
Identifiers: Product ID 44206-455_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264SPL ID 411c01a7-0ae7-45d2-8b4c-cbe99a2ba264
Pharmacologic class: Human Immunoglobulin G

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N444206045510 followed by a unit qualifier and the quantity

Package 44206-0455-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125350

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125350
Product	Strength	Form · route	Labeler	Product NDC
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-458
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-454
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-451
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-452
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-456
Hizentrahuman immunoglobulin g	Human immunoglobulin g .2 g/mL	LiquidSubcutaneous	CSL Behring AG	44206-457